Anika Therapeutics (ANIK) SEC Filings: History & Chart

Anika Therapeutics, Inc.(ANIK)

Medical - Specialties · Bedford, MA

$19.12-0.61 (-3.09%)

Delayed quote: Oct 6, 2026, 10:24 AM EDT

About Anika Therapeutics, Inc.

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain management family, which includes established treatments like Monovisc, Orthovisc, Cingal, and Hyvisc, all designed to alleviate discomfort from osteoarthritis. The company's joint preservation and restoration offerings are extensive, comprising approximately 150 bone-sparing joint technology products, alongside solutions for sports medicine soft tissue repair and orthopedic regenerative therapies. Furthermore, Anika leverages its HA expertise in a non-orthopedic product family, developing applications such as adhesion barriers, advanced wound care products, ophthalmic solutions, and ear, nose, and throat treatments. Anika Therapeutics, Inc. was established in 1983 and is based in Bedford, Massachusetts.

Bedford, MA

235 employees

www.anika.com

Healthcare / Medical - Specialties

Sector: Healthcare
Industry: Medical - Specialties
CEO: Stephen D. Griffin

View full financials

Form	Filing Date	Accepted	Document
144	Aug 7, 2026	Aug 7, 2026	View filing
4	Aug 5, 2026	Aug 5, 2026	View filing
SC 13G/A	Jul 31, 2026	Jul 31, 2026	View filing
S-8	Jul 29, 2026	Jul 29, 2026	View filing
10-Q	Jul 29, 2026	Jul 29, 2026	View filing
8-K	Jul 29, 2026	Jul 29, 2026	View filing
SC 13G/A	Jul 17, 2026	Jul 17, 2026	View filing
8-K	Jul 14, 2026	Jul 14, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
8-K	Jun 23, 2026	Jun 23, 2026	View filing
DEFA14A	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 5, 2026	Jun 5, 2026	View filing
DEFA14A	Jun 1, 2026	Jun 1, 2026	View filing
4	May 4, 2026	May 4, 2026	View filing
4	Apr 30, 2026	Apr 30, 2026	View filing
10-Q	Apr 30, 2026	Apr 29, 2026	View filing
SC 13G	Apr 29, 2026	Apr 29, 2026	View filing
8-K	Apr 29, 2026	Apr 29, 2026	View filing
ARS	Apr 28, 2026	Apr 28, 2026	View filing
DEFA14A	Apr 28, 2026	Apr 28, 2026	View filing
DEF 14A	Apr 28, 2026	Apr 28, 2026	View filing
SC 13G/A	Mar 26, 2026	Mar 26, 2026	View filing
4	Mar 23, 2026	Mar 23, 2026	View filing
4	Mar 17, 2026	Mar 17, 2026	View filing
4	Mar 17, 2026	Mar 17, 2026	View filing
4	Mar 17, 2026	Mar 17, 2026	View filing

SEC Filings

Recent Filings